(Q51669881)

English

Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission.

scientific article published in May 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/12789902

1 reference

Europe PubMed Central

Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. (English)

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/12789902

cystic fibrosis

0 references

0 references

author name string

Lisa Saiman

1

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/12789902

Jane Siegel

2

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/12789902

Cystic Fibrosis Foundation

3

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/12789902

publication date

1 May 2003

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/12789902

Infection Control and Hospital Epidemiology

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/12789902

24

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/12789902

5 Suppl

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/12789902

S6-52

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/12789902

Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Staphylococcus aureus infections

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Persistence of Staphylococcus aureus strains among cystic fibrosis patients over extended periods of time

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Anaerobic conditions induce expression of polysaccharide intercellular adhesin in Staphylococcus aureus and Staphylococcus epidermidis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Antibiotic prophylaxis in infants and young children with cystic fibrosis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Management of pulmonary disease in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Methicillin resistant Staphylococcus aureus (MRSA) infection in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Factors influencing outcomes in cystic fibrosis: a center-based analysis.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

An organizational climate intervention associated with increased handwashing and decreased nosocomial infections.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Behavioral interventions to improve infection control practices

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Control of vancomycin-resistant enterococcus in health care facilities in a region.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Nosocomial respiratory syncytial virus infections: the cost-effectiveness and cost-benefit of infection control

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Control of vancomycin-resistant enterococci at a community hospital: efficacy of patient and staff cohorting.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Multiple Isolates of Pseudomonas aeruginosa with Differing Antimicrobial Susceptibility Patterns from Patients with Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

To gown or not to gown: the effect on acquisition of vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Management of Pseudomonas aeruginosa lung infection in Danish cystic fibrosis patients.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Estimated risk of cross-infection with Pseudomonas aeruginosa in Danish cystic fibrosis patients.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Outbreak of Campylobacter food-poisoning in Northern Ireland

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Epidemiology of Pseudomonas cepacia in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Microbiological processing of respiratory specimens from patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Burkholderia cepacia. Management issues and new insights.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Disinfection of respirator tubing: a comparison of chemical versus hot water machine-assisted processing

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Selective media for the quantitation of bacteria in cystic fibrosis sputum.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Antimicrobial activity of home disinfectants and natural products against potential human pathogens

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Microbiology of airway disease in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Effects of sodium bicarbonate, vinegar, acetic and citric acids on growth and survival of Yersinia enterocolitica

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Burkholderia cepacia lower respiratory tract infection associated with exposure to a respiratory therapist

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Persistence and variability of Stenotrophomonas maltophilia in cystic fibrosis patients, Madrid, 1991-1998.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Pseudomonas cepacia in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosa

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Candida osteomyelitis and diskitis after spinal surgery: an outbreak that implicates artificial nail use.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Postoperative Serratia marcescens wound infections traced to an out-of-hospital source.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Guideline for infection control in healthcare personnel, 1998

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Polyphasic Taxonomy in the Genus Burkholderia Leading to an Emended Description of the Genus and Proposition of Burkholderia vietnamiensis sp. nov. for N2-Fixing Isolates from Rice in Vietnam

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Infection withBurkholderia cepaciaComplex Genomovars in Patients with Cystic Fibrosis: Virulent Transmissible Strains of Genomovar III Can ReplaceBurkholderia multivorans

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Microbiology of sputum from patients at cystic fibrosis centers in the United States

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Comparison of two commercial systems (Vitek and MicroScan-WalkAway) for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Ward floors and other surfaces as reservoirs of hospital infection

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Surface disinfection: should we do it?

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

A common source outbreak of Acinetobacter pulmonary infections traced to Wright respirometers

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Outbreak of Enterobacter cloacae related to understaffing, overcrowding, and poor hygiene practices

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Nosocomial Legionnaires' Disease Caused by Aerosolized Tap Water from Respiratory Devices

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Home nebulizer use among patients with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Institutional outbreaks of rotavirus diarrhoea: potential role of fomites and environmental surfaces as vehicles for virus transmission

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Transmission of Mycobacterium tuberculosis by a fiberoptic bronchoscope. Identification by DNA fingerprinting

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Patient-to-patient transmission of hepatitis C virus during colonoscopy

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Levels of microbial contamination on surgical instruments

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Association of contaminated gloves with transmission of Acinetobacter calcoaceticus var. anitratus in an intensive care unit

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Variable morbidity of respiratory syncytial virus infection in patients with underlying lung disease: a review of the PICNIC RSV database. Pediatric Investigators Collaborative Network on Infections in Canada.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Infection control: reducing the psychological effects of isolation.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Emotional reactions of children to isolation in a cancer hospital

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Does isolation of patients with infections induce mental illness?

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

The psychological consequences of source isolation: a review of the literature

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Cluster of cases of invasive aspergillosis in a transplant intensive care unit: evidence of person-to-person airborne transmission.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Allergic bronchopulmonary aspergillosis in cystic fibrosis: reported prevalence, regional distribution, and patient characteristics. Scientific Advisory Group, Investigators, and Coordinators of the Epidemiologic Study of Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Three cases of pulmonary aspergilloma in adult patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Infections in patients with cystic fibrosis following lung transplantation.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Epidemiology of chronic Pseudomonas aeruginosa infections in the airways of lung transplant recipients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Lack of transmission of mycobacterium abscessus among patients with cystic fibrosis attending a single clinic

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Non-tuberculous mycobacteria in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Lung transplantation in cystic fibrosis: consensus conference statement

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Annual influenza vaccination: immune response in patients over 10 years.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Acute severe deterioration in cystic fibrosis associated with influenza A virus infection

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Impact of influenza on morbidity in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Nontuberculous Mycobacteria in Adult Patients with Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Mycobacterial isolations in young adults with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

An outbreak of mycobacterial furunculosis associated with footbaths at a nail salon

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Nosocomial outbreaks/pseudo-outbreaks caused by nontuberculous mycobacteria

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Diagnosis and Treatment of Disease Caused by Nontuberculous Mycobacteria

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Bacterial colonisation with Xanthomonas maltophilia--a retrospective study in a cystic fibrosis patient population.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Controlled study of Pseudomonas cepacia and Pseudomonas maltophilia in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Xanthomonas maltophilia misidentified as Pseudomonas cepacia in cultures of sputum from patients with cystic fibrosis: a diagnostic pitfall with major clinical implications.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Stenotrophomonas maltophilia infection in children

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Nonrespiratory Stenotrophomonas maltophilia infection at a children's hospital

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Transmissibility and infection control implications of Burkholderia cepacia in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

An epidemic Burkholderia cepacia complex strain identified in soil

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Burkholderia cepacia complex bacteria from clinical and environmental sources in Italy: genomovar status and distribution of traits related to virulence and transmissibility

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Burkholderia cepacia genomovar III Is a common plant-associated bacterium.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

The pseudomonas hot-foot syndrome

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Outbreak of severe Pseudomonas aeruginosa infections caused by a contaminated drain in a whirlpool bathtub

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

An episodic outbreak of genetically related Burkholderia cepacia among non-cystic fibrosis patients at a university hospital.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Airborne dissemination of Burkholderia (Pseudomonas) cepacia from adult patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Microbiology of lung infection in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

An epidemic of burkholderia cepacia transmitted between patients with and without cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Comparative hygienic surveillance of contamination with pseudomonads in a cystic fibrosis ward over a 4-year period

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in a cystic fibrosis clinic

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Pseudomonas aeruginosa cross-colonization and persistence in patients with cystic fibrosis. Use of a DNA probe

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis. Summer Camp Study Group

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Gender gap in cystic fibrosis mortality

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF. European Epidemiologic Registry of Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Early bacteriologic, immunologic, and clinical courses of young infants with cystic fibrosis identified by neonatal screening

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Methicillin-resistant Staphylococcus aureus: impact at a national cystic fibrosis centre

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Predictive 5-year survivorship model of cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Determinants of mortality from cystic fibrosis in Canada, 1970-1989.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Survival following Burkholderia cepacia sepsis in a patient with cystic fibrosis treated with corticosteroids.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Pseudomonas cepacia infection in cystic fibrosis: an emerging problem

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relatives

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Vancomycin-resistant Staphylococcus aureus: perspectives on measures needed for control

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Are the epidemiology and microbiology of methicillin-resistant Staphylococcus aureus changing?

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Clonal features of community-acquired methicillin-resistant Staphylococcus aureus in children.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Genome and virulence determinants of high virulence community-acquired MRSA

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Current trends in community-acquired methicillin-resistant Staphylococcus aureus at a tertiary care pediatric facility.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Effect of Hand Cleansing with Antimicrobial Soap or Alcohol-Based Gel on Microbial Colonization of Artificial Fingernails Worn by Health Care Workers

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Epidemiology Of Chronic Pseudomonas aeruginosa Infections In Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Identifiers

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/12789902

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/12789902

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51669881&oldid=1218482487"